Invoy Technologies, LLC

Management Team

Dr. Ahmad founded Invoy to commercialize and build upon her inventions and novel designs in biosensor technologies. Since founding Invoy, she has recruited an experienced board and diversified team and raised multiple millions in investment capital. She has executed a series of partnerships and intellectual property transactions and positioned the company for product launch. Her experiences in sensor development and clinical study design have been key in Invoy’s ability to successfully execute a demanding product development program and obtain 510(k) clearance. Dr. Ahmad is a frequent presenter at biotechnology seminars and conferences. She holds a Ph.D. in biomedical engineering and was a Goldwater scholar and National Science Foundation fellow.

Dr. Satterfield is principally responsible for design, development and manufacture of Invoy’s cartridge systems, as well as management of clinical trials. Dr. Satterfield has substantial experience in biotech startups, having co-founded a VC-backed microfluidics company and then bootstrapped his own startup with $1.5M to develop and sell two new molecular diagnostic tests. Dr. Satterfield has invented various molecular diagnostic assays that were subsequently used by Sandia National Laboratories and the United States Army Medical Research Institute of Infectious Disease. Dr. Satterfield has a Ph.D. in biomedical engineering.

Dr. Martineau is principally responsible for the design and development of bioinstrumentation aspects of Invoy’s device. Dr. Martineau has nearly ten years of training and experience in the field of sensors and instrumentation with a biological emphasis. He has experience in the overall product development lifecycle from idea generation to 510(k) clearance. Prior to joining Invoy, he was engaged in high-profile work in a photosynthetic micro-organism production project, utilizing his expertise in sensors, scientific measurement and systems design. Dr. Martineau has a Ph.D. in biomedical engineering.

Mr. Smith has 13 years of experience in the industrial and product design industry, creating and developing new products from concept to manufacturing. His professional experience spans exhibit design, power-tool design, facility imaging, automotive component design, and medical equipment design and engineering. Mr. Smith has aided many start-ups in developing products and brand identities, and brought these consumer products from napkin sketch to manufacturing to market. He holds a B.S. in industrial design.

Mr. Ahmad is responsible for Invoy’s embedded and web-based software as well as various aspects of graphic design. In prior projects, his work has spanned from initial concept to large-scale deployment and maintenance of software systems. He has consulted for large companies such as Microsoft and Freescale, but has had start-up experience as well. His main research focus is human computer interactions and software systems. Mr. Ahmad has an MS in computer science from Stanford with four publications and two best paper awards at leading computer science conferences. He is currently pursuing a PhD in computer science at MIT.

Dr. Hartzfeld has 20 years experience working in FDA-regulated industries, including medical devices. Her experience includes quality system development and implementation, laboratory controls, regulatory affairs, cGMP training, PAI readiness, and FDA 483 warning letter response writing. Dr. Hartzeld has diverse experience with both large corporations and small pre-revenue companies. Dr. Hartzfeld has a Ph.D. in chemistry, and a strong technical background in analytical chemistry and organic synthesis.

Advisory Board

Dr. Gavin has been working with Invoy for the past three years to develop its clinical acceptance program. Dr. Gavin is the past president of the American Diabetes Association (ADA) and was voted Clinician of the Year by ADA in Diabetes in 1991. He is a member of the Board of Baxter International, Amylin Pharmaceuticals, and Nuvelo Pharmaceuticals. Dr. Gavin is immediate past chairman of the National Diabetes Education Program and a past member of the Advisory Council to the NIDDK. He is also chairman of the Data Safety Monitoring Board for the VA Cooperative Diabetes Study. Dr. Gavin is a Clinical Professor of Medicine at Emory University and was the president of the Morehouse School of Medicine. He holds a Ph.D. in biochemistry and an MD with specialization in endocrinology.

Mr. Garcia is an experienced attorney trained in the legal and business aspects of the biosciences and has substantial litigation experience. He has been a commissioner for the Arizona Biomedical Research Commission, which supports translational medical research and the State of Arizona's investment in the biosciences. He is the current Chair of the Government Affairs Committee for the Arizona Bioindustry Association.